Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
---|---|---|---|---|---|
10520-1 | TCS PIM-1 1 | 1235170 | |||
10519-1 | TAPI-0 | 3035404 | |||
10518-1 | Sulindac sulfide | 5352624 | |||
10517-1 | Ro 32-0432 | RO-320432 | 127757 | ||
10516-1 | Ribavirin | Tribavirin | 37542 | ||
10515-1 | QNZ | EVP4593 | 509554 | ||
10514-1 | PS-1145 | 9949093 | |||
10513-1 | Nelfinavir | Viracept | 64143 | ||
10512-1 | Methylglyoxal | Acetylformaldehyde; Pyruvaldehyde | 880 | ||
10511-1 | Mebendazole | Vermox | 4030 | ||
10510-1 | LY294002 | LY-294002 | 3973 | ||
10509-1 | GM6001 | Ilomastat; Galardin; GM-6001 | 132519 | ||
10508-1 | FTase Inhibitor I | B581 | 132887 | ||
10507-1 | Disulfiram | Tetraethylthiuram disulfide; TETD | 3117 | ||
10506-1 | Dichloroacetate | 25975 | |||
10505-1 | Chloroquine | 2719 | |||
10504-1 | Chk2 inhibitor II | BML-277 | 9969021 | ||
10503-1 | Celecoxib | Celebrex; Celebra; Celecox; Onsenal; Solexa; SC-58635; YM-177 | 2662 | ||
10502-1 | Bromopyruvic acid | 3-bromopyruvic acid; Bromopyruvate | 70684 | ||
10501-1 | 2-deoxyglucose | 2-deoxy-D-glucose; 2-Desoxy-D-glucose; 2-DG | 9062 | ||
10348-1 | Z-Leu-Leu-Norvalinal | MG-115 | LSM-6358 | 9868928 | |
10346-1 | Valproic acid | Depakine | LSM-4620 | 3549980 | |
10345-3 | Torkinib | PP242 | LSM-6357 | 57347681 | |
10344-1 | Olomoucine II | LSM-6356 | 10067756 | ||
10343-1 | Baicalein | LSM-6355 | 5281605 |